J 2020

Diagnostic Reliability, Accuracy and Safety of Ultrasound-guided Biopsy and Ascites Puncture in Primarily Inoperable Ovarian Tumours

VLASÁK, Pavel, Jiří BOUDA, Jan KOSTUN, Denis BEREZOVSKIY, Michal ZIKÁN et. al.

Základní údaje

Originální název

Diagnostic Reliability, Accuracy and Safety of Ultrasound-guided Biopsy and Ascites Puncture in Primarily Inoperable Ovarian Tumours

Autoři

VLASÁK, Pavel (203 Česká republika), Jiří BOUDA (203 Česká republika), Jan KOSTUN (203 Česká republika), Denis BEREZOVSKIY (203 Česká republika), Michal ZIKÁN (203 Česká republika), Vít WEINBERGER (203 Česká republika, domácí), Ondrej ONDIC (203 Česká republika), Zdeněk RUŠAVÝ (203 Česká republika), Radek KUČERA (203 Česká republika), Ondřej TOPOLČAN (203 Česká republika), Zdeněk NOVOTNÝ (203 Česká republika) a Jiří PRESL (203 Česká republika, garant)

Vydání

Anticancer Research, Athens, Greece, 2020, 0250-7005

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Řecko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.480

Kód RIV

RIV/00216224:14110/20:00115742

Organizační jednotka

Lékařská fakulta

UT WoS

000538104800060

Klíčová slova anglicky

Tru-Cut biopsy; ovarian cancer; ascites; puncture

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 1. 4. 2021 14:08, Mgr. Tereza Miškechová

Anotace

V originále

Background/Aim: To compare the diagnostic reliability, accuracy and safety of ultrasound-guided biopsy (Tru-Cut biopsy) and ascites puncture in patients with a primarily inoperable malignant ovarian tumor. Patients and Methods: This is a retrospective analysis of the studied methods in consecutively examined patients and a prospective validation of these methods. 79 women with a suspected primarily inoperable ovarian tumor underwent Tru-Cut biopsies and were included in the ultrasound-guided biopsy group. In addition, 55 patients after ascites puncture were enrolled in the comparison group. Both procedures were performed in 48 patients for the prospective validation. Results: Significant differences in favour of ultrasound-guided biopsy were found in all studied variables (malignancy confirmation 72.9% vs. 95.8%, tumor origin 52.1% vs. 89.6%, histologic subtype 43.8% vs. 85.4% and accuracy, i.e. agreement of preoperative and definitive diagnosis 43.7% vs. 95.4%). Conclusion: Ultrasound-guided biopsy is an accurate, reliable, safe and minimally invasive method. Owing to the high reliability and accuracy, it has the capacity to replace ascites puncture with cytologic examination or a more invasive method (laparoscopy, laparotomy) for adequate tumor sampling.